3-119810178-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_003889.4(NR1I2):c.315C>T(p.Ser105Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00162 in 1,609,474 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0081 ( 14 hom., cov: 32)
Exomes 𝑓: 0.00094 ( 15 hom. )
Consequence
NR1I2
NM_003889.4 synonymous
NM_003889.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.02
Publications
4 publications found
Genes affected
NR1I2 (HGNC:7968): (nuclear receptor subfamily 1 group I member 2) This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized. [provided by RefSeq, Jul 2008]
NR1I2 Gene-Disease associations (from GenCC):
- pediatric lymphomaInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 3-119810178-C-T is Benign according to our data. Variant chr3-119810178-C-T is described in ClinVar as [Benign]. Clinvar id is 773133.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.02 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00806 (1228/152354) while in subpopulation AFR AF = 0.0283 (1178/41586). AF 95% confidence interval is 0.027. There are 14 homozygotes in GnomAd4. There are 560 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NR1I2 | NM_003889.4 | c.315C>T | p.Ser105Ser | synonymous_variant | Exon 3 of 9 | ENST00000393716.8 | NP_003880.3 | |
NR1I2 | NM_022002.3 | c.432C>T | p.Ser144Ser | synonymous_variant | Exon 3 of 9 | NP_071285.1 | ||
NR1I2 | NM_033013.3 | c.315C>T | p.Ser105Ser | synonymous_variant | Exon 3 of 9 | NP_148934.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NR1I2 | ENST00000393716.8 | c.315C>T | p.Ser105Ser | synonymous_variant | Exon 3 of 9 | 1 | NM_003889.4 | ENSP00000377319.3 | ||
NR1I2 | ENST00000337940.4 | c.432C>T | p.Ser144Ser | synonymous_variant | Exon 3 of 9 | 1 | ENSP00000336528.4 | |||
NR1I2 | ENST00000466380.6 | c.315C>T | p.Ser105Ser | synonymous_variant | Exon 3 of 9 | 1 | ENSP00000420297.2 | |||
NR1I2 | ENST00000474090.1 | n.603C>T | non_coding_transcript_exon_variant | Exon 3 of 3 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00805 AC: 1225AN: 152236Hom.: 14 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1225
AN:
152236
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00216 AC: 505AN: 234112 AF XY: 0.00173 show subpopulations
GnomAD2 exomes
AF:
AC:
505
AN:
234112
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000942 AC: 1372AN: 1457120Hom.: 15 Cov.: 33 AF XY: 0.000806 AC XY: 584AN XY: 724696 show subpopulations
GnomAD4 exome
AF:
AC:
1372
AN:
1457120
Hom.:
Cov.:
33
AF XY:
AC XY:
584
AN XY:
724696
show subpopulations
African (AFR)
AF:
AC:
1009
AN:
33378
American (AMR)
AF:
AC:
84
AN:
44088
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26014
East Asian (EAS)
AF:
AC:
0
AN:
39532
South Asian (SAS)
AF:
AC:
4
AN:
85772
European-Finnish (FIN)
AF:
AC:
0
AN:
52268
Middle Eastern (MID)
AF:
AC:
6
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
120
AN:
1110176
Other (OTH)
AF:
AC:
149
AN:
60126
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
81
162
244
325
406
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00806 AC: 1228AN: 152354Hom.: 14 Cov.: 32 AF XY: 0.00752 AC XY: 560AN XY: 74490 show subpopulations
GnomAD4 genome
AF:
AC:
1228
AN:
152354
Hom.:
Cov.:
32
AF XY:
AC XY:
560
AN XY:
74490
show subpopulations
African (AFR)
AF:
AC:
1178
AN:
41586
American (AMR)
AF:
AC:
32
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5176
South Asian (SAS)
AF:
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8
AN:
68040
Other (OTH)
AF:
AC:
9
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
60
120
180
240
300
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 29, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.